FORT LAUDERDALE, FL - January 27, 2026 - PRESSADVANTAGE - An educational resource published by Grace Point Treatment ...
A clinical trial at Brown University Health to treat chronic low back pain with a one-time, non-surgical injection treatment ...
A central nervous system (CNS) tumor has prompted the FDA to place clinical holds on two Regenxbio gene therapies, including ...
Multiple sclerosis (MS) is a debilitating disease with few treatment options. But in a new clinical trial, scientists have tested a promising new therapy involving injections of stem cells, which ...
A new study led by researchers at the UNC School of Medicine and Cartesian Therapeutics, found that immunotherapy can help ...
“For decades, the diabetes world has focused on lowering sugar, not on treating the root cause of the disease nor on stopping its progression” said Dr. Dror Chevion, co-founder and CEO of Concenter ...
An AAV vector genome integration event associated with PLAG1 overexpression was identified in a preliminary analysis of the resected tumor.
SAN ANTONIO – It’s common knowledge that diabetics receive their insulin through injections or pumps. However, many people don’t know of a new option: inhalable insulin. The inhaler called Afrezza, ...
The placebo-controlled, double-blind, randomised Phase I trial involved 100 healthy participants.
Opus Genetics launches gene therapy clinical trial for MERTK-related retinitis pigmentosa: Research Triangle Park, North Carolina Wednesday, January 28, 2026, 16:00 Hrs [IST] Opus ...
Stocktwits on MSN
RGNX shares pare losses as Wall Street dismisses gene therapy clinical hold spurred selloff as an overreaction
Leerink said the premarket selloff in shares underscores the degree of surprise on the news, feeding into the "FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results